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The Chediak-Higashi (CH) 1 syndrome is an inher- 
ited  disorder  of humans  (2)  and  certain  mutant 
strains of mice (1, 7), mink (I 1), and cattle (16).  It 
is  characterized  by  partial  oculocutaneous  albi- 
nism,  increased  susceptibility  to  pyogenic  infec- 
tions,  and  several  functional  abnormalities  of 
leukocytes including defective lysosomal degranu- 
lation  and  impaired  chemotaxis (24).  An acceler- 
ated  phase  of  the  disease,  diagnosed  as  a  lym- 
phoma-like malignancy, commonly occurs in man 
(2).  The presence of giant granules in virtually all 
granule-containing cells  is  pathognomonic of the 
disease. 
We  recently  described  an  abnormality  of con- 
canavalin  A  (Con  A)  distribution  on  polymor- 
phonuclear leukocytes (PMN) from CH mice that 
suggested  a defect in  microtubule (MT) assembly 
in these cells (15).  I n PM N from various sources as 
well  as  in  lymphocytes,  virus-transformed  3T3 
fibroblasts (SV3T3), and other cells, the disassem- 
bly  of  MT,  for  example  by  cold  or  colchicine 
treatment, favors the aggregation of Con A into a 
surface cap (reviewed in  reference  13). Consistent 
with  this,  PMN  from  normal  black  mice show  a 
random  surface distribution of Con A except after 
incubation  with colchicine which  permits cap for- 
mation.  By  contrast,  Con  A  is  capped  spontan- 
eously on  PMN  from  the  beige or CH  mouse to 
the  same  degree  as  on  colchicine-treated normal 
cells.  Most  importantly,  we  also  showed  that  de- 
fective 3'5' cyclic GMP (cyclic GMP) generation 
~Abbreviations used in  this paper." carbachol,  car- 
bamylcholine;  CH,  Chediak-Higashi;  Con  A,  con- 
canavalin  A; cyclic GMP,  3'5' cyclic GMP;  MT,  mi- 
crotubules;  PMA,  phorbol  myristate  acetate;  PMN, 
polymorphonuclear leukocytes. 
was the likely cause of the impaired MT function 
in  CH  cells.  It  was  found  that  cyclic GMP  and 
agents  such  as  carbamylcholine  (carbachol)  and 
phorbol  myristate  acetate  (PMA)  that  increase 
cyclic GMP  levels (6)  normalize the  surface  dis- 
tribution  of Con  A on  CH  PMN  and  antagonize 
the colchicine effect on  normal  PMN. 
We  considered  the  unifying  hypothesis  that 
defective cyclic GMP generation could underly all 
characteristics  of  the  disease,  and  selected  the 
fibroblast  for  analysis  of morphological  features 
which  might  be expected to develop in  long-term 
experiments. 
In  this  report  we show that  agents that  elevate 
cyclic GMP  prevent the  formation of giant gran- 
ules  in  cultured  embryonic  fibroblasts  from  CH 
mice.  We  first  demonstrate  that  cultured  CH 
fibroblasts develop giant  granules  during  incuba- 
tion  in  vitro.  We  then  show  that  CH  cells  incu- 
bated  in  medium supplemented with carbacbol or 
PMA  develop  a  new  population  of morphologi- 
cally  normal granules.  In  addition  we report that 
CH cells are more susceptible than normal cells to 
shape changes induced by colchicine; this property 
is normalized by carbachol. 
MATERIALS AND  METHODS 
Isolation  and  Culture  of  Embryonic  Skin 
Fibroblasts 
A CH (C57/6J,  bg/bg)  female mouse mated  with a 
CH male and a black (C57/6J,  +/+) female mated with 
a black male were sacrificed on the  14th day of gesta- 
tion. The uteri were dissected out, the CH homozygotic 
or normal embryos were removed, and fibroblasts were 
isolated from the skin of the dorsal surface by the method 
of Moscona  (12). The  fibroblasts  were maintained  in 
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supplemented with  penicillin and  streptomycin (Grand 
Island Biological Co., Grand Island, N.Y.) and contain- 
ing  10%  fetal  calf serum  (FCS).  Cells  were  frozen  in 
batches after I wk in culture and thawed at intervals for 
use. Vigorous growth was maintained for approximately 
5 wk after thawing. 
For the experiments reported here, cells (between 0.2 
x  10  ~ and 0.5  x  10  ~) were plated in 3.5-cm petri dishes 
containing three  15-mm glass cover slips.  The medium, 
with  or  without  added  drugs,  was  changed daily.  The 
cultures  reached  confluency in  8-10 days.  Preliminary 
experiments  showed  that  the  drug  of  major  interest, 
carhachol, had no effect on the growth characteristics of 
the cells.  Fibroblasts plated  at approximately  10  + cells 
per dish were maintained in medium with or without 10 -~ 
M carbachol (the highest drug concentration employed in 
this  study).  Growth  curves  were  obtained  by  daily 
counting of cells harvested by trypsinization from three 
dishes. As shown in Fig.  I, carbachol did not significantly 
affect the growth rate or the cell density at confluence of 
CH  fibroblasts.  Similar  results  were  obtained  with 
normal mouse fibroblasts (not shown). 
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Growth  curves  of  CH  mouse  fibroblasts. 
Cells  (approximately  10  + fibroblasts  per  culture  dish) 
were  grown  to  confluency in  medium  with or without 
added carbachol (10 -5 M). At daily intervals, groups of 
three cultures were trypsinized, and the cells from each 
dish  were  counted  in  duplicate.  Each  point  represents 
the  average  of  six  determinations.  O,  CH  fibroblasts 
grown  in  medium  alone.  0,  CH  fibroblasts grown  in 
medium supplemented with carbachol. 
Fluorescence Microscopy 
Granule  development  was  monitored  by  removing 
cover slips from the petri dishes at intervals and incubat- 
ing  the  cells  with  acridine  orange  (1:10 e)  in  phos- 
phate-buffered saline (PBS) for between 2 and 5 min at 
37~  The distribution of fluorescence on stained cells 
was examined by epi-illumination with a Zeiss Universal 
fluorescence microscope  using an  FITC  filter and  500 
dichroic mirror for excitation, a 40￿  planapochromatic 
objective,  and  53  barrier filter.  Acridine orange stains 
lysosomes an intense orange color against a background 
of green cytoplasm  and  nucleus (18,  25).  100 cells per 
cover  slip  were  routinely  scored  for  the  presence  or 
absence of giant granules. The distribution of granules 
was  determined  with  confluent  cultures  since  rapidly 
dividing CH cells contain a  mixture in varying propor- 
tions of large and small granules, whereas confluent CH 
ceils contain a majority of giant granules. 
R ESU LTS 
The  morphology  of  lysosomal  granules  in  CH 
fibroblasts is dramatically  different from  normal. 
Confluent CH  fibroblasts (10-14 days  in culture) 
show  giant  granules  which  cluster  in  the  perinu- 
clear area  in about 60% of cells.  Most granules in 
the  remaining  40%  of  cells  are  also  larger  than 
normal. This is illustrated in Fig. 2 a and b. Two of 
the cells contain giant granules and the third shows 
a  majority  of  granules  which  are  considerably 
larger than those in normal cells (Fig. 2 at).  In one 
cell a giant granule may be in the process of fusing 
with  a  smaller granule.  Some  granules  which  are 
not significantly larger than those  in normal cells 
can also be seen. 
In  marked  contrast  with  the  untreated  fibro- 
blasts, CH cells grown in the presence of carbachol 
(10 -+  M)  contain  only  small  granules  in  91%  of 
cells  at  confluence,  and  these  granules  are  well 
dispersed  throughout  the  cytoplasm  (Fig.  2  c). 
One,  or at most two large granules were observed 
in  each  of the  remaining 9%  of cells and  may be 
partly due to dilution of giant granules present in 
the  original  cell  population.  The  morphology  of 
carbachol-treated CH  fibroblasts is in fact identi- 
cal to that of normal embryonic fibroblasts grown 
to confluence in either the presence or the absence 
of drug (Fig.  2  d). 
The  minimum  effective  dose  of  carbachol  on 
fibroblast  granule  morphology  was  estimated  by 
titrating granule  size  at confluence in cells grown 
in the presence of carbachol between  10 -5  M  and 
10 -1~ M.  Giant granule  formation  was  prevented 
206  BRtEF  NOTES FIGURE 2  Distribution of lysosomes in normal and CH mouse fibroblasts. Primary fibroblasts were grown 
to confluency (2 wk) in the presence and absence of carbachol  or PMA. Cells were stained with acridine 
orange and photographed with  Kodak  Ektachrome film. (a)  and (b) CH  fibroblasts without drug. Giant 
lysosomes  are  clustered  in  the  perinuclear  area.  (c)  CH  fibroblasts  grown  with  l0 -5  M  carbachol. 
Lysosomes are small and dispersed. A  similar distribution of granules is seen in cells grown with  10-* M 
and  10-* M  carbachol as well as with  l0 ng/ml PMA. (d) Normal fibroblasts containing small dispersed 
granules. Carbachol and PMA have no effect on granule morphology in these cells. Note that in normal and 
carbachol-treated  fibroblasts  lysosomes are  dispersed  well  into peripheral  processes.  In CH  fibroblasts, 
virtually no peripheral  lysosomes are observed.  Initial magnification, 500. 
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and was depressed at  10-lo M.  We also observed 
that cells treated with  10 -5 M carbachol plus 10 -5 
M atropine, the classical antagonist of muscarinic 
drugs,  developed  giant granules  in  40%  of cells, 
compared  with  9%  of cells  when  only carbachol 
was present i'n "the medium. 
By contrast with  cells exposed  continuously to 
carbachol,  cells  grown  to  approximately  50% 
confluency  (5  days)  with  carbachol  and  then 
maintained to full confluency (10 days) in medium 
lacking carbachol were indistinguishable  from cells 
which  were  never exposed  to the drug: either the 
granules regain the tendency to  fuse  once carba- 
chol is removed or else new granules which fuse to 
form  aberrant  structures  are  generated  during 
subsequent cell growth. Cells grown to confluence 
(10 days) without carbachol and then exposed to 
carhachol for a further 3  5 days show no apparent 
reversion of giant granules to small granules. Thus, 
it  seems likely that carbachol prevents formation 
of abnormal granules. The drug probably does not 
modify the morphology of preformed granules. 
Striking differences in colchicine sensitivity be- 
tween CH  fibroblasts and normal and carbachol- 
treated  CH  cells  were  also noted by light micro- 
scope examination of cell  monolayers from  near- 
confluent cultures.  When  colchicine (10 -6  M)  is 
included in  the  incubation medium during a  30- 
min incubation, CH  cells  become very  small and 
rounded and are  readily detached from the cover 
slip during gentle rinsing. By contrast, CH  fibro- 
blasts grown in the  presence of carbachol do  not 
show  these shape changes in the presence of 10  6 
M  colchicine when  incubated for  30  rain.  When 
incubation is continued beyond  I h, the relatively 
colchicine-insensitive normal cells  and carbachol- 
treated  CH  cells  will  eventually  round  up  and 
detach  from the substratum. 
Inclusion  of  PMA  (10 -9  M)  in  the  culture 
medium was as effective as carbachol in preventing 
giant granule formation. However, more detailed 
studies (dose-response and growth curves) were not 
performed  with  PMA  since,  in  addition  to  its 
induction of increased cyclic GMP  levels,  it  has 
other multiple sites of action (9, 26). Cyclic GMP 
itself was  not used  in these  long-term experiments 
since it could not be expected to escape  degrada- 
tion when included in the tissue culture system. 
DISCUSSION 
In  our  previous study (15)  we obtained evidence 
for  a  defect  in  MT  function in  PMN  from  CH 
mice  that  could  be  corrected  by cyclic GMP  or 
agents that promote cyclic GMP generation. This 
was  based  on  a  similar  surface  property  (an 
extreme degree of Con A capping) in CH cells and 
colchicine-treated  normal  cells  and  reduction  in 
cap  formation  to  normal  levels  by  elevation  of 
cyclic GMP. These functional studies were consist- 
ent with the morphological evidence of Weissmann 
and co-workers (8, 22) for a role of cyclic GMP in 
promoting MT assembly in PMN. These authors 
have demonstrated that the number of MT observ- 
able  in  thin  sections  of normal human  PMN  is 
increased in the presence of zymosan particles or 
the C5a component of complement and is further 
increased  by  brief exposure of the cells  to cyclic 
GMP, PMA, or cholinergic drugs. The mechanism 
by which  cyclic GMP  promotes  MT assembly is 
not yet understood. 
In the  present study we  report  that  CH  fibro- 
blasts  are  extremely  sensitive  to  shape  changes 
induced by colchicine. This again suggests  defec- 
tive  MT  function. Carbachol,  a  cholinergic drug 
that  stimulates cyclic GMP generation in leuko- 
cytes,  antagonizes  the  colchicine  effect  on  CH 
fibroblast  shape.  This  result  is  consistent  with 
enhancement of MT stability after drug treatment. 
In  addition,  we  show  that  the  aberrant  giant 
lysosomal granules that are pathognomonic of the 
CH syndrome develop in cultured primary embry- 
onic fibroblasts from CH mice. These granules are 
particularly prominent in confluent cultures, sug- 
gesting  that  they  arise  by  fusion  of  preformed 
granules  as  previously  suggested  for  the  bone 
marrow  cells  of CH  mink  in  vivo (5).  We show 
here  that  inclusion  in  the  growth  medium  of 
carbachol  or  PMA  prevents  the  appearance  of 
these abnormal structures. 
Direct  measurements of cyclic  GMP  levels  of 
normal and CH  cells  before and  after carbachol 
treatment are in progress. These data are required 
before  we  can  conclude  with  certainty  that  im- 
proved  MT function in PMN and fibroblasts and 
normal  granule  morphology  in  fibroblasts  are 
directly  related  to  increased  cyclic  GMP  levels 
rather than to some other effect  of the drug. The 
mechanism  by  which  decreased  cyclic  GMP  or 
impaired  MT  polymerization could lead to giant 
granule formation also remains to be established. 
One possibility is based on our previous observa- 
tion  that  the  composition of the  membranes of 
phagocytic  vesicles  in  normal  rabbit  PMN  is 
altered by colchicine treatment, probably second- 
ary to changes in surface protein mobility ( 14, 20). 
20~  BRIEF  NOTES Since endocytic vesicles may serve as the nuclei for 
lysosomal  development  in  cells  such  as  macro- 
phages  (4)  and  fibroblasts  (10),  it  is possible  that 
the membrane  of the lysosome is abnormal  in the 
MT-defective CH cell. For example, it may lack a 
surface-derived  "recognition  signal"  which  nor- 
mally prevents fusion with other lysosomes. Alter- 
natively,  the  aberrant  granules  could  result  from 
the inability of lysosomes of MT-defective cells to 
process  materials  normally.  Thus,  Patzelt  and 
co-workers  (17)  have  observed  the  reversible  for- 
mation  of  large  autophagic  vacuoles  in  hepatic 
cells after inhibition  of MT assembly  with colchi- 
cine. Electron microscope studies of giant granules 
in CH cells have revealed abnormal inclusions (23) 
reminiscent of these colchicine-induced autophagic 
vacuoles. 
Interestingly,  CH  fibroblasts  are  similar  to 
SV40  virus-transformed  3T3  mouse  embryonic 
fibroblasts in several respects. We consistently find 
the  transformed  cells  to  be  more  susceptible  to 
shape  change  and  detachment  by  colchicine than 
normal  parental  3T3  fibroblasts.  In  addition,  we 
previously reported  that  CH  fibroblasts cap spon- 
taneously with Con  A  and that  SV3T3 fibroblasts 
also  show Con  A  capping  after  brief exposure to 
colchicine (13,  21).  Capping  in  both CH  and  col- 
chicine-treated  SV3T3  fibroblasts  was  prevented 
by cyclic GMP.  By contrast, normal 3T3 and C57/ 
6J  +/+  fibroblasts  show  a  random  surface  dis- 
tribution of Con A before and after treatment with 
colchicine or cyclic GMP (13).  This suggests that 
both  CH  and  SV3T3  fibroblasts  may  show  im- 
paired  MT  assembly  related  to  inadequate  cyclic 
GMP  generation,  with  the defect  being  more  ex- 
treme  in  CH  cells.  In  support  of this,  Rudland 
and co-workers (19)  have reported that the ability 
of  SV3T3  cells  to  modulate  cyclic  GMP  levels, 
for example  in  response  to  serum  growth  factors, 
is  impaired  compared  with  nontransformed  cells. 
Further,  Brinkley and  co-workers (3)  have used  a 
fluorescent  antibody  technique  to  show  that  in- 
tact  MT are considerably  more prominent  in  3T3 
than  SV3T3 cells. 
SUMMARY 
Primary embryonic fibroblasts isolated from beige 
(Chediak-Higashi)  mice  develop  pathognomonic 
giant  granules  in  vitro.  Inclusion  in  the  culture 
medium  of carbamylcholine  (carbachol)  or  phor- 
bol myristate acetate (PMA) results in the genera- 
tion of morphologically normal granules. 
Chediak-Higashi  fibroblasts are highly suscepti- 
ble  to  shape  changes  induced  by  colchicine. This 
abnormal  property  is  also corrected  by carbachol 
and  PMA. 
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